Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
about
APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathyTreatment Strategies of Adult Primary Focal Segmental Glomerulosclerosis: A Systematic Review Focusing on the Last Two DecadesPro: 'The usefulness of biomarkers in glomerular diseases'. The problem: moving from syndrome to mechanism--individual patient variability in disease presentation, course and response to therapyGlomerular diseases: FSGS.Targeted exome sequencing integrated with clinicopathological information reveals novel and rare mutations in atypical, suspected and unknown cases of Alport syndrome or proteinuriaThe impact of sex in primary glomerulonephritis.Angiotensin-converting enzyme gene polymophism in adult primary focal segmental glomerulosclerosis.Moxibustion Alleviates Injury in a Rat Focal Segmental Glomerulosclerosis Model.Proteomic profiling identifies haptoglobin as a potential serum biomarker for steroid-resistant nephrotic syndrome.Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGSFocal and segmental glomerulosclerosis: clinical and kidney biopsy correlations.Clinical value of NPHS2 analysis in early- and adult-onset steroid-resistant nephrotic syndrome.Clinical features and outcomes of IgA nephropathy with nephrotic syndrome.MYH9 genetic variants associated with glomerular disease: what is the role for genetic testing?An overview of the British Columbia Glomerulonephritis network and registry: integrating knowledge generation and translation within a single frameworkThe need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologists.Clinical and molecular characterization of patients with heterozygous mutations in wilms tumor suppressor gene 1.Therapeutic approach to FSGS in children.A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis.Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group.Clinical trial of focal segmental glomerulosclerosis in children and young adults.Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: mutations in multiple glomerular genes may influence disease severityActhar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS.The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome.Circulating suPAR in two cohorts of primary FSGS.Complete Remission in the Nephrotic Syndrome Study Network.Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic SyndromeRenal function and proteinuria after successful immunosuppressive therapies in patients with FSGS.Value of a complete or partial remission in severe lupus nephritis.Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGSChanging the Paradigm for the Treatment and Development of New Therapies for FSGS.Recurrent Primary Focal Segmental Glomerulosclerosis Managed With Intensified Plasma Exchange and Concomitant Monitoring of Soluble Urokinase-Type Plasminogen Activator Receptor-Mediated Podocyte β3-integrin ActivationEffects of Therapy on Urine Neutrophil Gelatinase-Associated Lipocalin in Nondiabetic Glomerular Diseases with Proteinuria.Experience with tacrolimus in children with steroid-resistant nephrotic syndrome.Clinicopathological correlation and treatment response of primary focal segmental glomerulosclerosis in adults and adolescents.Treatment of idiopathic FSGS with adrenocorticotropic hormone gel.Cyclosporine A for the treatment of refractory nephrotic syndrome with renal dysfunction.Novel biomarkers in glomerular disease.Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients.
P2860
Q24631837-DF68F12C-E19F-4C88-964F-48354CE138E4Q26752836-6995E378-4D96-40F8-ADB6-3D7C3FD42346Q27015909-18149F3A-AED2-404D-A856-EEFC6872933FQ27687257-FE352DE8-7B1E-43FB-9AD0-6560AB2A38ADQ28534316-CB2B8E97-A0EC-44FE-A347-5CE509314D3DQ33313682-5553C795-B756-4358-B09B-50A1CC032898Q33688313-77096B2B-054F-4340-90F9-3C3DF3C8E814Q33786923-94DF86E4-B329-4182-8194-2B487B404F76Q34324615-B4B56262-35A8-4CA4-8EC6-77390AC73004Q34455143-7F5D16CA-2EAF-4D0B-9E76-98FA2A7D626DQ34556394-77C9ECDA-9277-48B4-97FE-926F070079D3Q34639646-A0D467CE-428A-4D6C-AEAB-8AFD50929D74Q34660643-9D85B25F-0B97-43B8-B909-7EAA9C78CC36Q34990741-3B4C337A-D036-4339-8D9B-1EB067E3997FQ35028015-1FBE96FD-D213-4FF3-A7C7-82EABEB7A287Q35310613-B5C8DE91-580C-48FF-860E-952882233D7CQ35576147-FF7EC48C-F510-4BB8-B87C-28C1D1BBC7C1Q35614311-D87B88CA-DA3E-4DDE-AEFB-ED85697EDEA8Q35669295-DAC36773-BC33-4A0D-9FA7-9D2CD8E0D339Q35704498-0D6D5DC6-B244-4189-AB99-3962839104ADQ35837532-16212820-CC40-4470-89F8-15974702C978Q35959709-AEF97838-DC3E-4C0C-8E10-7A100B6371BAQ35976834-9845B4CF-5901-48D5-89BA-8AEE31A61C69Q36003095-EA7E5BC6-4780-4AB9-867D-4B1738663604Q36098017-5AAA21CD-3CC8-4049-8A91-5858F1F6AA85Q36426091-C7E573E9-EA15-437F-9D0E-2395B5319A6BQ36432859-015217E6-47BD-48D6-8F77-FCDFF41C61BFQ36543103-1A2B9BB9-AD45-4F15-B3E7-58F23A1A67F5Q36583388-86806216-A5E2-46B3-9B12-0D12F38C810EQ36666936-E68847DC-A6AE-49FE-9AA4-05860F172D1DQ36686985-5319CDC1-20E5-4572-8DED-6B61A23E9D03Q36717656-444F6622-AD06-45A7-961D-BCE69CABFB7EQ36987307-E4EF0BEA-1C2E-4EE4-A777-4D4FD4498D25Q37157018-0E5252E8-3AC8-4A50-AE2D-1089A01E417FQ37229944-F437E5A8-54EC-44DC-BC63-8E300A8AE5E8Q37241092-4DE61CEB-17FD-4A16-9959-998FCD964EB9Q37359035-68E2E141-E7FF-45FD-8202-0F3184CFB305Q37434558-A0BC3ED1-29F8-4805-9F9D-75AEB3B7DE4AQ37658483-411911C4-0B67-4CCB-BDC9-B6559CBA0D2DQ37928188-14BEE071-987D-4F31-884A-A98D3F2A84AD
P2860
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
@ast
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
@en
type
label
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
@ast
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
@en
prefLabel
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
@ast
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
@en
P2093
P356
P1476
Focal and segmental glomerulosclerosis: definition and relevance of a partial remission.
@en
P2093
Catherine A Wall
Daniel C Cattran
James W Scholey
Judith A Miller
Stéphan Troyanov
Toronto Glomerulonephritis Registry Group
P304
P356
10.1681/ASN.2004070593
P577
2005-02-16T00:00:00Z